UniProt ID | HNRH1_HUMAN | |
---|---|---|
UniProt AC | P31943 | |
Protein Name | Heterogeneous nuclear ribonucleoprotein H | |
Gene Name | HNRNPH1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 449 | |
Subcellular Localization | Nucleus, nucleoplasm. | |
Protein Description | This protein is a component of the heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the substrate for the processing events that pre-mRNAs undergo before becoming functional, translatable mRNAs in the cytoplasm. Mediates pre-mRNA alternative splicing regulation. Inhibits, together with CUGBP1, insulin receptor (IR) pre-mRNA exon 11 inclusion in myoblast. Binds to the IR RNA. Binds poly(RG).. | |
Protein Sequence | MMLGTEGGEGFVVKVRGLPWSCSADEVQRFFSDCKIQNGAQGIRFIYTREGRPSGEAFVELESEDEVKLALKKDRETMGHRYVEVFKSNNVEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGITLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRYIEIFKSSRAEVRTHYDPPRKLMAMQRPGPYDRPGAGRGYNSIGRGAGFERMRRGAYGGGYGGYDDYNGYNDGYGFGSDRFGRDLNYCFSGMSDHRYGDGGSTFQSTTGHCVHMRGLPYRATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEDAVAAMSKDKANMQHRYVELFLNSTAGASGGAYEHRYVELFLNSTAGASGGAYGSQMMGGMGLSNQSSYGGPASQQLSGGYGGGYGGQSSMSGYDQVLQENSSDFQSNIA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MMLGTEGG -------CCCCCCCC | 4.52 | 22814378 | |
1 | Sulfoxidation | -------MMLGTEGG -------CCCCCCCC | 4.52 | 28465586 | |
2 | Acetylation | ------MMLGTEGGE ------CCCCCCCCC | 4.80 | 22223895 | |
2 | Sulfoxidation | ------MMLGTEGGE ------CCCCCCCCC | 4.80 | 28465586 | |
5 | Phosphorylation | ---MMLGTEGGEGFV ---CCCCCCCCCEEE | 27.74 | 20860994 | |
14 | Sumoylation | GGEGFVVKVRGLPWS CCCEEEEEEECCCCC | 22.40 | - | |
14 | Sumoylation | GGEGFVVKVRGLPWS CCCEEEEEEECCCCC | 22.40 | - | |
14 | Ubiquitination | GGEGFVVKVRGLPWS CCCEEEEEEECCCCC | 22.40 | - | |
21 | Phosphorylation | KVRGLPWSCSADEVQ EEECCCCCCCHHHHH | 9.03 | 25159151 | |
22 | Glutathionylation | VRGLPWSCSADEVQR EECCCCCCCHHHHHH | 3.25 | 22555962 | |
22 | S-palmitoylation | VRGLPWSCSADEVQR EECCCCCCCHHHHHH | 3.25 | 26865113 | |
23 | Phosphorylation | RGLPWSCSADEVQRF ECCCCCCCHHHHHHH | 32.99 | 25159151 | |
29 | Methylation | CSADEVQRFFSDCKI CCHHHHHHHHHCCEE | 39.49 | 115479139 | |
34 | S-nitrosocysteine | VQRFFSDCKIQNGAQ HHHHHHCCEECCCCC | 3.97 | - | |
34 | S-nitrosylation | VQRFFSDCKIQNGAQ HHHHHHCCEECCCCC | 3.97 | 19483679 | |
35 | Sumoylation | QRFFSDCKIQNGAQG HHHHHCCEECCCCCE | 52.93 | - | |
35 | Acetylation | QRFFSDCKIQNGAQG HHHHHCCEECCCCCE | 52.93 | 25953088 | |
35 | Sumoylation | QRFFSDCKIQNGAQG HHHHHCCEECCCCCE | 52.93 | 28112733 | |
35 | Ubiquitination | QRFFSDCKIQNGAQG HHHHHCCEECCCCCE | 52.93 | 21906983 | |
44 | Methylation | QNGAQGIRFIYTREG CCCCCEEEEEEEECC | 20.80 | 54556625 | |
47 | Phosphorylation | AQGIRFIYTREGRPS CCEEEEEEEECCCCC | 9.31 | 24719451 | |
54 | Phosphorylation | YTREGRPSGEAFVEL EEECCCCCCCEEEEE | 48.15 | 22617229 | |
63 | Phosphorylation | EAFVELESEDEVKLA CEEEEECCHHHHEEE | 64.07 | 19664994 | |
68 | Sumoylation | LESEDEVKLALKKDR ECCHHHHEEEEHHCH | 26.45 | - | |
72 | Sumoylation | DEVKLALKKDRETMG HHHEEEEHHCHHHHC | 47.20 | - | |
72 | Sumoylation | DEVKLALKKDRETMG HHHEEEEHHCHHHHC | 47.20 | - | |
81 | Methylation | DRETMGHRYVEVFKS CHHHHCCEEEEEHHC | 31.31 | - | |
87 | Sumoylation | HRYVEVFKSNNVEMD CEEEEEHHCCCEEEE | 58.40 | 28112733 | |
87 | Ubiquitination | HRYVEVFKSNNVEMD CEEEEEHHCCCEEEE | 58.40 | 21890473 | |
88 | Phosphorylation | RYVEVFKSNNVEMDW EEEEEHHCCCEEEEE | 23.36 | 21712546 | |
98 | 2-Hydroxyisobutyrylation | VEMDWVLKHTGPNSP EEEEEEEEECCCCCC | 29.51 | - | |
98 | Acetylation | VEMDWVLKHTGPNSP EEEEEEEEECCCCCC | 29.51 | 21466224 | |
98 | Methylation | VEMDWVLKHTGPNSP EEEEEEEEECCCCCC | 29.51 | 23644510 | |
98 | Sumoylation | VEMDWVLKHTGPNSP EEEEEEEEECCCCCC | 29.51 | 28112733 | |
98 | Ubiquitination | VEMDWVLKHTGPNSP EEEEEEEEECCCCCC | 29.51 | 21890473 | |
100 | Phosphorylation | MDWVLKHTGPNSPDT EEEEEEECCCCCCCC | 53.39 | 23927012 | |
104 | Phosphorylation | LKHTGPNSPDTANDG EEECCCCCCCCCCCC | 27.56 | 23927012 | |
107 | Phosphorylation | TGPNSPDTANDGFVR CCCCCCCCCCCCCEE | 30.64 | 22167270 | |
114 | Methylation | TANDGFVRLRGLPFG CCCCCCEEECCCCCC | 19.19 | - | |
122 | S-nitrosocysteine | LRGLPFGCSKEEIVQ ECCCCCCCCHHHHHH | 5.56 | - | |
122 | S-nitrosylation | LRGLPFGCSKEEIVQ ECCCCCCCCHHHHHH | 5.56 | 19483679 | |
123 | Phosphorylation | RGLPFGCSKEEIVQF CCCCCCCCHHHHHHH | 43.40 | 22777824 | |
151 | Phosphorylation | PVDFQGRSTGEAFVQ CCCCCCCCHHHHHHH | 47.81 | 18669648 | |
152 | O-linked_Glycosylation | VDFQGRSTGEAFVQF CCCCCCCHHHHHHHH | 37.37 | 23301498 | |
152 | Phosphorylation | VDFQGRSTGEAFVQF CCCCCCCHHHHHHHH | 37.37 | 30087585 | |
161 | Phosphorylation | EAFVQFASQEIAEKA HHHHHHHHHHHHHHH | 29.63 | 28450419 | |
167 | Acetylation | ASQEIAEKALKKHKE HHHHHHHHHHHHHHH | 50.42 | 23954790 | |
167 | Ubiquitination | ASQEIAEKALKKHKE HHHHHHHHHHHHHHH | 50.42 | 21890473 | |
170 | Ubiquitination | EIAEKALKKHKERIG HHHHHHHHHHHHHHC | 58.66 | - | |
171 | Ubiquitination | IAEKALKKHKERIGH HHHHHHHHHHHHHCH | 61.84 | - | |
180 | Phosphorylation | KERIGHRYIEIFKSS HHHHCHHHHHHHHHC | 9.38 | 20068231 | |
185 | Sumoylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | - | |
185 | 2-Hydroxyisobutyrylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | - | |
185 | Acetylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | 25825284 | |
185 | Methylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | 21689879 | |
185 | Succinylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | 23954790 | |
185 | Sumoylation | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | - | |
185 | Ubiquitination | HRYIEIFKSSRAEVR HHHHHHHHHCCCCHH | 53.86 | 21890473 | |
186 | Phosphorylation | RYIEIFKSSRAEVRT HHHHHHHHCCCCHHH | 17.82 | 20068231 | |
187 | Phosphorylation | YIEIFKSSRAEVRTH HHHHHHHCCCCHHHC | 35.78 | 20068231 | |
193 | Phosphorylation | SSRAEVRTHYDPPRK HCCCCHHHCCCCCHH | 29.93 | 28796482 | |
195 | Phosphorylation | RAEVRTHYDPPRKLM CCCHHHCCCCCHHHH | 29.54 | 28796482 | |
199 | Methylation | RTHYDPPRKLMAMQR HHCCCCCHHHHHCCC | 50.56 | - | |
200 | Ubiquitination | THYDPPRKLMAMQRP HCCCCCHHHHHCCCC | 48.68 | 21890473 | |
206 | Methylation | RKLMAMQRPGPYDRP HHHHHCCCCCCCCCC | 25.67 | - | |
210 | Phosphorylation | AMQRPGPYDRPGAGR HCCCCCCCCCCCCCC | 30.42 | 22461510 | |
212 | Dimethylation | QRPGPYDRPGAGRGY CCCCCCCCCCCCCCC | 26.21 | - | |
212 | Methylation | QRPGPYDRPGAGRGY CCCCCCCCCCCCCCC | 26.21 | 18961567 | |
217 | Dimethylation | YDRPGAGRGYNSIGR CCCCCCCCCCCCCCC | 43.84 | - | |
217 | Methylation | YDRPGAGRGYNSIGR CCCCCCCCCCCCCCC | 43.84 | 24396111 | |
219 | Phosphorylation | RPGAGRGYNSIGRGA CCCCCCCCCCCCCCC | 12.36 | - | |
221 | Phosphorylation | GAGRGYNSIGRGAGF CCCCCCCCCCCCCCH | 20.24 | 30576142 | |
224 | Dimethylation | RGYNSIGRGAGFERM CCCCCCCCCCCHHHH | 30.07 | - | |
224 | Methylation | RGYNSIGRGAGFERM CCCCCCCCCCCHHHH | 30.07 | 24383111 | |
230 | Dimethylation | GRGAGFERMRRGAYG CCCCCHHHHHCCCCC | 22.96 | - | |
230 | Methylation | GRGAGFERMRRGAYG CCCCCHHHHHCCCCC | 22.96 | 18960657 | |
232 | Methylation | GAGFERMRRGAYGGG CCCHHHHHCCCCCCC | 39.85 | 26494631 | |
233 | Dimethylation | AGFERMRRGAYGGGY CCHHHHHCCCCCCCC | 25.42 | - | |
233 | Methylation | AGFERMRRGAYGGGY CCHHHHHCCCCCCCC | 25.42 | 12018757 | |
236 | Phosphorylation | ERMRRGAYGGGYGGY HHHHCCCCCCCCCCC | 21.08 | 20090780 | |
240 | Phosphorylation | RGAYGGGYGGYDDYN CCCCCCCCCCCCCCC | 15.62 | 20090780 | |
243 | Phosphorylation | YGGGYGGYDDYNGYN CCCCCCCCCCCCCCC | 10.98 | 20090780 | |
246 | Phosphorylation | GYGGYDDYNGYNDGY CCCCCCCCCCCCCCC | 13.95 | 17360941 | |
249 | Phosphorylation | GYDDYNGYNDGYGFG CCCCCCCCCCCCCCC | 13.37 | 17360941 | |
253 | Phosphorylation | YNGYNDGYGFGSDRF CCCCCCCCCCCCCCC | 16.49 | 20090780 | |
257 | Phosphorylation | NDGYGFGSDRFGRDL CCCCCCCCCCCCCCC | 24.29 | 25348954 | |
259 | Dimethylation | GYGFGSDRFGRDLNY CCCCCCCCCCCCCCC | 37.30 | - | |
259 | Methylation | GYGFGSDRFGRDLNY CCCCCCCCCCCCCCC | 37.30 | 30759959 | |
262 | Dimethylation | FGSDRFGRDLNYCFS CCCCCCCCCCCCCCC | 42.40 | - | |
262 | Methylation | FGSDRFGRDLNYCFS CCCCCCCCCCCCCCC | 42.40 | 30759953 | |
266 | Phosphorylation | RFGRDLNYCFSGMSD CCCCCCCCCCCCCCC | 11.36 | 21945579 | |
267 | S-nitrosocysteine | FGRDLNYCFSGMSDH CCCCCCCCCCCCCCC | 1.81 | - | |
267 | Glutathionylation | FGRDLNYCFSGMSDH CCCCCCCCCCCCCCC | 1.81 | 22555962 | |
267 | S-nitrosylation | FGRDLNYCFSGMSDH CCCCCCCCCCCCCCC | 1.81 | 22178444 | |
269 | Phosphorylation | RDLNYCFSGMSDHRY CCCCCCCCCCCCCCC | 29.99 | 21945579 | |
272 | Phosphorylation | NYCFSGMSDHRYGDG CCCCCCCCCCCCCCC | 33.52 | 23401153 | |
276 | Phosphorylation | SGMSDHRYGDGGSTF CCCCCCCCCCCCCCC | 19.02 | 28152594 | |
281 | Phosphorylation | HRYGDGGSTFQSTTG CCCCCCCCCCCCCCC | 31.42 | 23401153 | |
282 | Phosphorylation | RYGDGGSTFQSTTGH CCCCCCCCCCCCCCC | 29.03 | 29978859 | |
285 | Phosphorylation | DGGSTFQSTTGHCVH CCCCCCCCCCCCCEE | 24.60 | 26330541 | |
286 | Phosphorylation | GGSTFQSTTGHCVHM CCCCCCCCCCCCEEE | 26.47 | 28555341 | |
287 | Phosphorylation | GSTFQSTTGHCVHMR CCCCCCCCCCCEEEC | 30.12 | 26330541 | |
290 | Glutathionylation | FQSTTGHCVHMRGLP CCCCCCCCEEECCCC | 2.08 | 22555962 | |
294 | Methylation | TGHCVHMRGLPYRAT CCCCEEECCCCCCCC | 28.72 | 115385249 | |
298 | Phosphorylation | VHMRGLPYRATENDI EEECCCCCCCCCCCC | 20.23 | 20090780 | |
301 | O-linked_Glycosylation | RGLPYRATENDIYNF CCCCCCCCCCCCHHC | 26.73 | 23301498 | |
301 | Phosphorylation | RGLPYRATENDIYNF CCCCCCCCCCCCHHC | 26.73 | 27987026 | |
306 | Phosphorylation | RATENDIYNFFSPLN CCCCCCCHHCCCCCC | 14.58 | 29255136 | |
310 | O-linked_Glycosylation | NDIYNFFSPLNPVRV CCCHHCCCCCCCEEE | 25.08 | 23301498 | |
310 | Phosphorylation | NDIYNFFSPLNPVRV CCCHHCCCCCCCEEE | 25.08 | 29255136 | |
328 | Phosphorylation | IGPDGRVTGEADVEF ECCCCCCCEECEEEE | 28.13 | - | |
346 | Phosphorylation | EDAVAAMSKDKANMQ HHHHHHHCCCCHHCC | 32.73 | - | |
349 | 2-Hydroxyisobutyrylation | VAAMSKDKANMQHRY HHHHCCCCHHCCHHH | 45.45 | - | |
349 | Ubiquitination | VAAMSKDKANMQHRY HHHHCCCCHHCCHHH | 45.45 | 21890473 | |
356 | Phosphorylation | KANMQHRYVELFLNS CHHCCHHHHHHHHHC | 8.99 | 27251275 | |
363 | Phosphorylation | YVELFLNSTAGASGG HHHHHHHCCCCCCCC | 23.06 | 28152594 | |
364 | Phosphorylation | VELFLNSTAGASGGA HHHHHHCCCCCCCCC | 28.21 | 27251275 | |
368 | Phosphorylation | LNSTAGASGGAYEHR HHCCCCCCCCCCHHE | 36.52 | 28152594 | |
372 | Phosphorylation | AGASGGAYEHRYVEL CCCCCCCCHHEEEEE | 18.62 | 28152594 | |
376 | Phosphorylation | GGAYEHRYVELFLNS CCCCHHEEEEEEEEC | 10.53 | 23879269 | |
424 | Phosphorylation | SGGYGGGYGGQSSMS CCCCCCCCCCCCCCC | 22.74 | 26074081 | |
428 | Phosphorylation | GGGYGGQSSMSGYDQ CCCCCCCCCCCHHHH | 31.14 | 26074081 | |
429 | Phosphorylation | GGYGGQSSMSGYDQV CCCCCCCCCCHHHHH | 14.74 | 26074081 | |
431 | Phosphorylation | YGGQSSMSGYDQVLQ CCCCCCCCHHHHHHH | 35.83 | 26074081 | |
441 | Phosphorylation | DQVLQENSSDFQSNI HHHHHHCCCHHHHHC | 30.45 | 26074081 | |
442 | Phosphorylation | QVLQENSSDFQSNIA HHHHHCCCHHHHHCC | 54.77 | 26074081 | |
446 | Phosphorylation | ENSSDFQSNIA---- HCCCHHHHHCC---- | 30.14 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
104 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of HNRH1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of HNRH1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT SER-310, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-63; SER-104 ANDSER-310, AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100; SER-104 ANDTHR-107, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 AND MET-2, PHOSPHORYLATION[LARGE SCALE ANALYSIS] AT SER-310, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-104 AND THR-107,AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 AND SER-310, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23, AND MASSSPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-100, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-246 AND TYR-306, ANDMASS SPECTROMETRY. |